Journal article
Robin N. Stringer, Xuechen Tang, Bohumila Jurkovičová-Tarabová, Mary Murphy, K. Liedl, Norbert Weiss
Molecular Brain, 2025
Molecular Brain, 2025
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Stringer, R. N., Tang, X., Jurkovičová-Tarabová, B., Murphy, M., Liedl, K., & Weiss, N. (2025). Functional characterization of a novel de novo CACNA1C pathogenic variant in a patient with neurodevelopmental disorder. Molecular Brain.
Chicago/Turabian
Click to copy
Stringer, Robin N., Xuechen Tang, Bohumila Jurkovičová-Tarabová, Mary Murphy, K. Liedl, and Norbert Weiss. “Functional Characterization of a Novel De Novo CACNA1C Pathogenic Variant in a Patient with Neurodevelopmental Disorder.” Molecular Brain (2025).
MLA
Click to copy
Stringer, Robin N., et al. “Functional Characterization of a Novel De Novo CACNA1C Pathogenic Variant in a Patient with Neurodevelopmental Disorder.” Molecular Brain, 2025.
BibTeX Click to copy
@article{robin2025a,
title = {Functional characterization of a novel de novo CACNA1C pathogenic variant in a patient with neurodevelopmental disorder},
year = {2025},
journal = {Molecular Brain},
author = {Stringer, Robin N. and Tang, Xuechen and Jurkovičová-Tarabová, Bohumila and Murphy, Mary and Liedl, K. and Weiss, Norbert}
}
Abstract
Mutations in CACNA1C, the gene encoding Cav1.2 voltage-gated calcium channels, are associated with a spectrum of disorders, including Timothy syndrome and other neurodevelopmental and cardiac conditions. In this study, we report a child with a de novo heterozygous missense variant (c.1973T > C; L658P) in CACNA1C, presenting with refractory epilepsy, global developmental delay, hypotonia, and multiple systemic abnormalities, but without overt cardiac dysfunction. Electrophysiological analysis of the recombinant Cav1.2 L658P variant revealed profound gating alterations, most notably a significant hyperpolarizing shift in the voltage dependence of activation and inactivation. Additionally, molecular modeling suggested that the L658P mutation disrupts interactions within the IIS5 transmembrane segment, reducing the energy barrier for state transitions and facilitating channel opening at more negative voltages. These findings establish L658P as a pathogenic CACNA1C variant primarily associated with severe neurological dysfunction and expands the phenotypic spectrum of CACNA1C-related disorders.